ReNAgade Therapeutics launches with $300M financing to unlock ‘limitless potential’ of RNA medicine 25-May-2023 By Isabel Cameron ReNAgade Therapeutics has announced a $300 million Series A financing round led by MPM BioImpact and F2 Ventures.